Acceder

Publicaciones - FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA

Cargando...
Iniesta-Navalon C, Rentero-Redondo L, Gomez-Espin R, Rios Saorin M, Nicolas de Prado I, Gascon-Canovas JJ. Exploring infliximab serum level variability in inflammatory bowel disease: Comprehensive analysis of patient subgroups and treatment outcomes. Gastroenterol Hepatol. 2025 May 23:502472. doi: 10.1016/j.gastrohep.2025.502472. Online ahead of print. English, Spanish. PubMed PMID: 40414284.
AÑO: 2025; IF: 2.2
40414284
Serrano Díaz L., Iniesta Navalón C., Gómez Espín R., Nicolás De Prado I., Bernal Morell E., Rentero Redondo L. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study. Gastroenterologia y Hepatologia. 1 June 2024. 47:553-561. 10.1016/j.gastrohep.2023.08.004
AÑO: 2024; IF: 2.2
37597745
Añez-Castaño R., Iniesta-Navalón C., Almanchel-Rivadeneyra M., García-Villalba E., Oliver-Galera E., Rentero-Redondo L. Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease. European Journal of Hospital Pharmacy. 2024. 10.1136/ejhpharm-2023-004075
AÑO: 2024; IF: 1.6
Serrano Diaz L, Iniesta Navalon C, Gomez Espin R, Nicolas De Prado I, Bernal Morell E, Rentero Redondo L. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study. Gastroenterol Hepatol. 2024 Jun-Jul;47(6):553-561. doi: 10.1016/j.gastrohep.2023.08.004. Epub 2023 Aug 18. English, Spanish. PubMed PMID: 37597745.
AÑO: 2024; IF: 2.2
37597745
Iniesta-Navalon C, Rios-Saorin M, Rentero-Redondo L, Anez-Castano R, Urbieta-Sanz E. Comparative evaluation of point of care assay with ELISA techniques for quantifying serum concentrations of ustekinumab in inflammatory bowel disease patients. Gastroenterol Hepatol. 2024 Oct 21:S0210-5705(24)00284-X. doi: 10.1016/j.gastrohep.2024.502277. Online ahead of print. English, Spanish. PubMed PMID: 39442691.
AÑO: 2024; IF: 2.2
39442691
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA